In development: Guidance, quality standards and advice
Showing 1 to 4 of 4
| Title | Type | Expected publication date |
|---|---|---|
| Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653] | Technology appraisal guidance | TBC |
| Insulin icodec for treating type 2 diabetes [ID6175] | Technology appraisal guidance | TBC |
| Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes [ID6259] | Technology appraisal guidance | |
| Type 2 diabetes in adults: management (medicines update) | NICE guideline |